AEPODIA
Aepodia’s history starts in 2007. Spin-out of a top 10 US Pharma Company, Aepodia was created by a group of experts in early-phase clinical development. Since its creation, Aepodia has confirmed its reputation by designing, preparing and conducting more than 90 Projects in healthy volunteers or patients with a strong focus on client’s needs and results outcomes. Aepodia has established solid and effective collaborations with pharmaceutical companies over the world (EU, US, Japan), as well as with biotech companies in Europe.
AEPODIA
Social Links:
Industry:
Biotechnology Consulting Legal Life Science Pharmaceutical
Founded:
2007-01-01
Address:
Louvain-la-neuve, Vlaams-Brabant, Belgium
Country:
Belgium
Website Url:
http://www.aepodia.com
Total Employee:
11+
Status:
Active
Contact:
+32010392011
Email Addresses:
[email protected]
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Apple Mobile Web Clips Icon Google Tag Manager Google Analytics Global Site Tag Google Universal Analytics Google Analytics 4 Nginx US Privacy User Signal Mechanism
Similar Organizations
Anglia DNA
Anglia DNA is an independent laboratory offering scientific services for DNA, drug, and alcohol testing.
Drugabilis
Drugabilis specializes in solid form characterisation and formulation development for human and animal health.
Future Care Capital
FCC is committed to engaging, educating and involving all generations in the development and delivery of unified health and care provision.
Marcus & Associates | Life Sciences Executive Search Experts
Marcus & Associates is a leading life sciences executive search firm helping clients acquire the industry's'​ most talented individuals.
Tecrea
Tecrea is the provider world leading cell and tissue delivery technology for research and drug development applications.
The Research Network
The Research Network is a Pharmaceutical R&D Scientific Consultancy, Project Management, Outsourcing, Training And Due Diligence Services.
Current Employees Featured
Founder
Newest Events participated
Participated in Partnerships in Clinical Trials Europe 2017
on 2017-11-28 as exhibitor
Official Site Inspections
http://www.aepodia.com
- Host name: 149.13.127.10
- IP address: 149.13.127.10
- Location: Clichy France
- Latitude: 48.9012
- Longitude: 2.3072
- Timezone: Europe/Paris
- Postal: 92110
More informations about "Aepodia"
Acepodia - Crunchbase Company Profile & Funding
Acepodia is a clinical-stage biotechnology business that is using its proprietary Antibody-Cell Conjugation (ACC) platform technology to produce first-in-class …See details»
Company Organization-Acepodia | POWERFUL, ACCESSIBLE CELL …
We sincerely thank you for your support to Acepodia. Personal Investment and Stock Affairs Agent Information PHONE: +886-2-xxxxxxxx. ADDRESS: xxxxxxxxxxx. Professional …See details»
Acepodia | POWERFUL, ACCESSIBLE CELL THERAPIES FOR …
Acepodia is a clinical-stage biotechnology company developing first-in-class cell therapies with its unique Antibody-Cell Conjugation (ACC) platform technology to address gaps in cancer care. …See details»
Acepodia - LinkedIn
Acepodia is a clinical-stage biotechnology company developing innovative and highly effective cell therapies for cancer that are broadly accessible for patients.See details»
Aepodia - Crunchbase Company Profile & Funding
Aepodia’s history starts in 2007. Spin-out of a top 10 US Pharma Company, Aepodia was created by a group of experts in early-phase clinical development.See details»
Acepodia (TPEX:6976) Company Profile & Description - Stock …
Apr 28, 2025 Acepodia, Inc. operates as a clinical stage biotechnology company. The company engages in developing cell therapies with its antibody cell conjugation (ACC) platform …See details»
Acepodia: Contact Details, Revenue, Funding, Employees and …
Acepodia is a clinical-stage biotechnology company developing accessible cancer cell therapies using its Antibody-Cell Conjugation (ACC) technology. By linking tumor-targeting antibodies to …See details»
Acepodia Biotech, Inc. - Drug pipelines, Patents, Clinical trials
About Acepodia Acepodia is a clinical-stage biotechnology company developing first-in-class cell therapies with its unique Antibody-Cell Conjugation (ACC) platform technology to address …See details»
Acepodia Company Profile - Office Locations, Competitors ... - Craft
Acepodia is a biotech company developing cell therapies for cancer. It leverages its proprietary bioconjugation ACC (antibody-cell conjugation) platform that links antibodies directly to …See details»
Acepodia Inc. - VentureRadar
Acepodia is pioneering next-generation technologies that effectively fight cancers. The company is developing first-in-class, off-the-shelf allogeneic cell therapies with significantly improved …See details»
Acepodia - Overview, News & Similar companies | ZoomInfo.com
View Acepodia (www.acepodia.com) location in California, United States , revenue, industry and description. Find related and similar companies as well as employees by title and much more. …See details»
Member Profile - TRPMA Official Website
Jun 19, 2017 Acepodia was founded in 2017 by Dr. Patrick Y. Yang, former EVP of Juno Therapeutics, Roche, and Genentech, and by Dr. Sonny Hsiao, UC Berkeley Cell Biologist …See details»
BIO Asia–Taiwan 2025 亞洲生技大會
Acepodia is a privately held biotechnology company focused on developing innovative, highly effective cell therapies to treat cancers. Acepodia is a clinical-stage biotechnology company …See details»
Acepodia snags $109M—and an early Zoom backer—to ... - Fierce …
Dec 2, 2021 Elsewhere in the C-suite, Acepodia has gone on a hiring spree since disclosing a $47 million series B in March. AbbVie cancer R&D veteran Thorsten Graef, M.D., Ph.D., joined …See details»
Aepodia Company Profile - Office Locations, Competitors ... - Craft
Aepodia is a company specialized in the strategy and delivery of drugs and the development of medical devices. It provides scientific consultancy as well as operational support across …See details»
Acepodia Secures $100 Million Series D Financing to Advance First …
Jun 6, 2023 Acepodia is a clinical-stage biotechnology company developing first-in-class cell therapies with its unique Antibody-Cell Conjugation (ACC) platform technology to address …See details»
Biocytogen and Acepodia Join Forces to Advance Bispecific …
Jan 7, 2025 Acepodia is transforming cancer and autoimmune disease treatment with first-in-class immune cell engagers that deliver enhanced and targeted potency through multiple …See details»
Acepodia picks up strong hand for cell therapies in $100M raise
Jun 6, 2023 Acepodia is ready to ante up its bet on cell therapy after turning over a brand new $100 million series D financing that will support the biotech's pipeline of medicines for solid …See details»
Acepodia Enters Strategic Clinical Collaboration with Pfizer to ...
Acepodia is a clinical-stage biotechnology company developing first-in-class cell therapies with its unique Antibody-Cell Conjugation (ACC) platform technology to address gaps in cancer care. …See details»
Acepodia Enters Strategic Clinical Collaboration with Pfizer to ...
Sep 4, 2024 With the agreement, Acepodia will retain all rights related to the progress of the program and future partnership opportunities. About Acepodia. Acepodia is a clinical-stage …See details»